|
|
Volumn 297, Issue 17, 2007, Pages 1868-1869
|
|
FDA sounds alert on anemia drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ERYTHROPOIETIN;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
ZIDOVUDINE;
ANEMIA;
BLOOD CLOT;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHRONIC KIDNEY DISEASE;
DRUG FATALITY;
DRUG LABELING;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
ERYTHROCYTE TRANSFUSION;
FOOD AND DRUG ADMINISTRATION;
HEAD AND NECK CANCER;
HEALTH HAZARD;
HEART INFARCTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LOW DRUG DOSE;
PRESCRIPTION;
PRIORITY JOURNAL;
RECOMMENDED DRUG DOSE;
SHORT SURVEY;
SIDE EFFECT;
STROKE;
TUMOR GROWTH;
ARTICLE;
RISK;
UNITED STATES;
ANEMIA;
DRUG LABELING;
ERYTHROPOIETIN, RECOMBINANT;
HUMANS;
RISK;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 34247887504
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.297.17.1868 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|